How are you managing patients with unfavorable intermediate-risk prostate cancer who would be eligible for RTOG 0232?  

Brachytherapy monotherapy, EBRT + ADT, or tri-modality therapy? What duration of ADT would you use?



Answer from: Radiation Oncologist at Community Practice

Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist at Jacob E Locke MD PA
Relying on subgroup analysis should be done with c...
Sign in or Register to read more